🟢 Tscan Therapeutics is trading 5.3% up in after-hours trading with no clear company-specific catalyst identified

Tscan Therapeutics is trading at $0.29, up +5.30% after-hours, with no clear company-specific catalyst identified for the October 6 increase.

• The company’s release page lists September 2 as its latest press release.
• Major indexes were up during the October 6 session, but that does not establish a cause for the after-hours move.